REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Farmasi Isihat Sdn. Bhd. (Malaysia)

Main Activities: Pharmacies and Drug Stores
Full name: Farmasi Isihat Sdn. Bhd. Profile Updated: January 24, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Farmasi Isihat Sdn. Bhd. is based in Malaysia, with the head office in Seri Manjung. The company operates in the Pharmacies and Drug Stores sector. It was incorporated on November 13, 2015. There was a net sales revenue drop of 21.38% reported in Farmasi Isihat Sdn. Bhd.’s latest financial highlights for 2023. Its’ total assets recorded a negative growth of 6.19%. In 2023, Farmasi Isihat Sdn. Bhd.’s net profit margin decreased by 3.66%.

Headquarters
144, Jalan Ppmp 9, Pusat Perdagangan Manjung Point 1
Seri Manjung; Perak; Postal Code: 32040

Contact Details: Purchase the Farmasi Isihat Sdn. Bhd. report to view the information.

Basic Information
Registered Capital:
Purchase the Farmasi Isihat Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Farmasi Isihat Sdn. Bhd. report to view the information.
Incorporation Date:
November 13, 2015
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
95%
Purchase this report to view the information.
5%
Company Performance
Financial values in the chart are available after Farmasi Isihat Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
-21.38%▼
Total operating revenue
-21.38%▼
Operating profit (EBIT)
-83.44%▼
EBITDA
-86.75%▼
Net Profit (Loss) for the Period
-88.64%▼
Total Assets
-6.19%▼
Total Equity
-11.48%▼
Operating Profit Margin (ROS)
-4.02%▼
Net Profit Margin
-3.66%▼
Return on Equity (ROE)
-28.07%▼
Debt/Equity
26.76%▲
Quick Ratio
0%
Cash Ratio
-0.05%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo